Piper Jaffray Maintains Overweight on Apyx Medical, Raises Price Target to $10

Piper Jaffray maintains Apyx Medical (NASDAQ:APYX) with a Overweight and raises the price target from $8 to $10.

Benzinga · 11/12/2019 13:30

Piper Jaffray maintains Apyx Medical (NASDAQ:APYX) with a Overweight and raises the price target from $8 to $10.